Antineoplastic and Endocrine Agents (L01-L02) AI

TEDAS your procurement assistant

Ask a question about this procurement

t

Procurement Object

  • What is being procured: Purchase of medicines, specifically antineoplastic and endocrine agents (according to the requirements in RHAD Annex I Technical Specification-Tender Form). The procurement is divided into 39 lots (e.g., Cyclophosphamide, Ifosfamide, Temozolomide, etc.).
  • Main technical requirements, characteristics: The goods offered must comply with the requirements presented in the RHAD Annex I Technical Specification-Tender Form. The Supplier must guarantee that the shelf life of the delivered goods is at…
     
    To see full summary, please log in or register.
t

👋 Hello! I am TEDAS – your procurement assistant 💼✨

What would you like to know about this procurement?

Note: This is preliminary information. For accuracy, please review all procurement documents.
Ask your questions here...

289398_ESPD_v2.0_laiendatud.xml

289398_hankepass_taiendavate_selgitustega.pdf

289398_hindamiskriteeriumid.pdf

289398_Lisa II Raamlepingu projekt.docx

289398_Lisa I Tehniline kirjeldus-pakkumuse vorm.xlsx

289398_RHAD üldosa.pdf

289398_vastavustingimused.pdf

289398.zip

Ready to get started?

Subscribe and enjoy all the benefits every day!